Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
4
×
life sciences
medicare
4
×
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
4
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
gene therapy
nivolumab
novartis
pfizer
alopecia areata
amarin
amgen
biogen
bristol-myers squibb
What
bio
roundup
companies
drug
life
new
patients
science
talk
advantages
approval
arena’s
bar
becker
billions
biogen’s
biopharmaceutical
bounty
brings
cig
comeback
convo
corner
deals
delivered
dollars
earlier
eaton
expect
expressing
failures
gamble
gene
healthcare
impact
ipo
littered
little
market
medco’s
Language
unset
Current search:
merck
×
medicare
×
" san francisco top stories "
×
" indiana top stories "
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More